Amyn Sayani

Amyn Sayani is a pharmaceutical industry professional with extensive experience in drug development and medical evidence. He currently holds the position of Director, Medical Evidence at AstraZeneca Canada.4

Professional Background

Amyn Sayani has over 20 years of experience in the pharmaceutical industry, covering various aspects of drug development.1 His expertise includes:

• Pre-clinical and pre-formulation development
• Formulation development
• Real-world evidence
• Outcomes research

Current Role

As the Director of Medical Evidence at AstraZeneca Canada, Amyn Sayani is responsible for:

• Overseeing real-world evidence initiatives
• Managing outcomes research projects
• Contributing to the company's medical evidence strategy

Additional Involvement

Beyond his primary role at AstraZeneca, Amyn Sayani is also involved in:

• The Canadian Society for Pharmaceutical Sciences, where he serves on the Board of Directors4
• Supporting AstraZeneca's investments in life sciences in Ontario and Canada2

Amyn Sayani's LinkedIn profile reflects his professional experience and current position at AstraZeneca, aligning with the username "amynsayani" mentioned in the query.13